Overview
- Across 96 GP surgeries using the device versus 109 comparators, 12,725 symptomatic patients received a 15‑second chest exam combining heart sounds with a rapid ECG analyzed by cloud AI.
- Patients examined with the tool were 2.33 times more likely to be diagnosed with heart failure within 12 months, 3.45 times for atrial fibrillation, and 1.92 times for valve disease.
- Two-thirds of AI-flagged suspected heart failure cases were not confirmed on BNP blood tests or imaging, indicating a substantial false-positive rate that can drive extra follow-up.
- Usage waned in practice, with 70% of GP sites given devices stopping or using them infrequently after a year, underscoring workflow and integration barriers.
- Findings were presented at the European Society of Cardiology congress and published in BMJ Open; the Eko Health device underpins planned rollouts in Wales, South London and Sussex.